In a lung cancer cohort enrolling 263 non-metastatic and non-operable NSCLC treated by radiotherapy alone or with chemotherapy, high OPN and CA-IX serum concentrations (two blood markers related to the hypoxia pathway) were identified as negatively impacting overall survival (OS) [141]. This evidence concerns the gene SPP1 and non-small cell lung carcinoma.